Literature DB >> 7060526

Binding of [3H]monohydroxytamoxifen by immature rat tissues in vivo.

V C Jordan, R A Bowser-Finn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7060526     DOI： 10.1210/endo-110-4-1281

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  7 in total

1.  The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.

Authors:  V Craig Jordan
Journal:  Ann Surg Oncol       Date:  2019-03-25       Impact factor: 5.344

Review 2.  Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.

Authors:  A C Tate; E R DeSombre; G L Greene; E V Jensen; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 4.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

5.  Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sites.

Authors:  B W Ennis; W E Stumpf
Journal:  Histochem J       Date:  1989-01

6.  The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells.

Authors:  Thomas Helland; Jennifer Gjerde; Simon Dankel; Ingvild S Fenne; Linn Skartveit; Andreas Drangevåg; Olivera Bozickovic; Marianne Hauglid Flågeng; Håvard Søiland; Gunnar Mellgren; Ernst A Lien
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 7.  Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.

Authors:  V Craig Jordan
Journal:  Breast Cancer Res Treat       Date:  2021-08-16       Impact factor: 4.872
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.